# Fulgent Genetics Inc. (FLGT) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $19.73, market value $543 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Fulgent Genetics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 1.7×**. Each dollar of revenue is priced at 1.7×.
- **Price / book: 0.5×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: -19.1%** (5-yr avg 4.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 35.6%**. Fulgent Genetics Inc. keeps 35.6% of revenue after the direct cost of what it sells.
- **Operating margin: -37.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -18.8%**. The company reported a net loss over the last twelve months.
- **Return on equity: -5.4%**. Return on equity is negative because earnings are negative.
- **Return on assets: -7.0%**. Each dollar of assets produces -7.0% of profit.

## Growth
- **Revenue growth (1 yr): 13.8%** (3-yr -19.5%/yr, 5-yr -5.2%/yr). Revenue grew 13.8% over the last year, against -5.2% a year compounded over five years: growth is accelerating.

## Financial health
- **Current ratio: 6.48** (quick 6.48). Current assets cover the next year's liabilities 6.48 times.
- **Altman Z-score: 4.81**. A Z-score of 4.81 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Fulgent Genetics Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -10.2%** (YTD -24.9%, 3-mo 3.0%). The shares are down 10.2% over twelve months including dividends.
- **From 52-week high: -36.4%** (46.6% above the low). Trading 36% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 53**. An RSI of 53 is neutral.
- **Beta (1 yr): 0.78** (volatility 59%). Beta of 0.78 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=FLGT · Page: https://foliofundamentals.com/stocks/flgt

Not investment advice.